18-Month mortality and perinatal exposure to zidovudine in West Africa

AIDS

Volumn 15, Issue 6, 2001, Pages 771-779

  Dabis, François ^a   Elenga, Narcisse ^b   Meda, Nicolas ^c   Leroy, Valériane ^a   Viho, Ida ^b   Manigart, Olivier ^c   Dequae Merchadou, Laurence ^a   Msellati, Philippe ^d   Sombie, Issiaka ^e  

^a INSERM   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

^c CENTRE MURAZ   (Burkina Faso)

^d Centre IRD de Petit Bassam   (Côte d’Ivoire)

^e NONE

Author keywords

Africa; Child mortality; HIV 1; Zidovudine

Indexed keywords

CD4 ANTIGEN; PLACEBO; ZIDOVUDINE;

AFRICA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT MORTALITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MATERNAL MORTALITY; NEWBORN; PERINATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; VERTICAL TRANSMISSION;

ADULT; AFRICA, WESTERN; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; RNA, VIRAL; ZIDOVUDINE;

EID: 0035853409     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200104130-00013     Document Type: Article

References (42)

1. Medical management of newborns and infants in developing countries
2. Integrated approach to child health in developing countries
3. Advances and research directions in the prevention of mother-to-child HIV-1 transmission
4. Randomized placebo-controlled trial of short-course antenatal zidovudine to reduce perinatal HIV transmission, Bangkok, Thailand
5. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'lvoire and Burkina Faso: A double-blind placebo-controlled multicentre trial
6. Randomized clinical trial of a short course of oral zidovudine to prevent mother-to-child transmission of HIV-1 in Abidjan, Côte d'lvoire
7. 15 Months efficacy of a maternal short regimen of oral zidovudine to reduce vertical transmission of HIV in African breast-fed children
8. 24-Month efficacy of short-course maternal zidovudine for the prevention of mother-to-child HIV-1 transmission in a breast-feeding population: A pooled analysis of two randomised clinical trials in West Africa
9. Estimating the rate of mother-to-child transmission of HIV: Report of a workshop on methodological issues, Ghent (Belgium), 17-20 February 1992
10. The PETRA study: Early and late efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1
11. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
12. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues
13. HIV nucleoside analogues: New adverse effects on mitochondria?
14. Recommendations on the safe and effective use of short-course ZDV for prevention of mother-to-child transmission of HIV
15. Methodology of intervention trials to reduce mother to child transmission of HIV with special reference to developing countries
16. Acquired immunodeflciency syndrome (AIDS): WHO/CDC case definition for AIDS
17. HIV infection in Africa
18. Mortality impact of AIDS in Abidjan, 1986-1992
19. Natural history of HIV type I infection in children: A five year prospective study in Rwanda
20. Retrospective study of maternal HIV-1 and HIV-2 infections and child survival in Abidjan, Côte d'lvoire
21. Impact of zidovudine post-perinatal exposure prophylaxis on vertical HIV-1 transmission: A prospective cohort study in 4 U.S. cities
22. Mitochondrial toxicity of perinatally administered zidovudine
23. Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial
24. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 study
25. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine
26. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women
27. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
28. Care of HIV-infected children in developing countries: Report of a workshop for clinical research. Paris, 26-27 September 1997
29. Relation of the course of HIV infection in children to the severity of the disease in their mother at delivery
30. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease
31. Shortened survival in infants vertically infected with human immunodeficiency virus with elevated p24 antigenemia
32. The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1
33. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy
34. Disease progression and early dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods
35. Prevention of infectious complications of pediatric HIV infection in Africa
36. Use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa
37. Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000